Adaptive Artificial Passive Immunity as a Suggested Strategy for Treatment of COVID-19 Critical Cases
May 2020 DOI 10.14302/issn.2691-8862.jvat-20-3311
Ahmed G. ElkabilyCorresponding author
Currently, the emergence of a novel human corona virus, SARS-CoV-2, has become a global health concern causing severe respiratory tract infections in humans. Human-to-human transmissions have been described with incubation times between 2-14 days, facilitating its spread via droplets, contaminated h…